Anaphylactic shock in a beta-blocked child: Usefulness of isoproterenol

Paediatric Anaesthesia

Volumn 17, Issue 9, 2007, Pages 897-899

  Momeni, Mona ^a   Brui, Barbara ^a   Baele, Philippe ^a   Matta, Amine ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Anaphylactic shock; Aprotinin; Beta blocker; Congenital heart disease; Isoproterenol; Pediatric cardiac surgery

Indexed keywords

ADRENALIN; APROTININ; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HETASTARCH; ISOPRENALINE; METHYLPREDNISOLONE; MIDAZOLAM; NADOLOL; ROCURONIUM; SEVOFLURANE; SUFENTANIL;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANESTHESIA INDUCTION; ARTICLE; ARTIFICIAL VENTILATION; ATRIOVENTRICULAR CANAL; BETA ADRENERGIC RECEPTOR BLOCKING; BRADYCARDIA; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ERUPTION; ENDOTRACHEAL INTUBATION; HEART SURGERY; HEMODYNAMICS; HUMAN; LUNG COMPLIANCE; LUNG PRESSURE; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANAPHYLAXIS; ANESTHESIA; AORTIC STENOSIS, SUBVALVULAR; APROTININ; ATRIOVENTRICULAR NODE; BRADYCARDIA; CHILD, PRESCHOOL; EPINEPHRINE; HEART RATE; HUMANS; ISOPROTERENOL; MALE; OXYGEN; SERINE PROTEINASE INHIBITORS; VASOCONSTRICTOR AGENTS;

EID: 34547678534     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2007.02276.x     Document Type: Article

References (14)

1. Levy JH, Pifarre R, Schaff HV et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor blood transfusion in patients undergoing repeat coronary artery bypass. Circulation 1995 92 : 2236 2244.
2. McDonough J, Gruenwald C. The use of aprotinin in pediatric patients: a review. J Extra Corpor Technol 2003 35 : 346 349.
3. Miller BE, Tosone SR, Tam VKH et al. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 1998 66 : 535 540.
4. Carrel TP, Schwanda M, Vogt PR et al. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only. Ann Thorac Surg 1998 66 : 153 158.
5. Dietrich W, Barankay A, Hähnel C et al. High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients. J Cardiothorac Vasc Anesth 1992 6 : 324 327.
6. Bidstrup BP, Harrison J, Royston D et al. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993 55 : 971 976.
7. Dietrich W, Späth P, Ebell A et al. Prevalence of anaphylactic reactions to aprotinin: Analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 1997 113 : 194 201.
8. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005 5 : 359 364.
9. Lang DM. Anaphylactoid and anaphylactic reactions. Hazards of beta-blockers. Drug Saf 1995 12 : 299 304.
10. Laxenaire MC, Torrens J, Moneret-Vautrin DA. Fatal anaphylactic shock in a patient treated with beta-blockers. Ann Fr Anesth Reanim 1984 3 : 435 435.
11. Javeed N, Javeed H, Javeed S et al. Refractory anaphylactoid shock potentiated by beta-blockers. Cathet Cardiovasc Diagn 1996 39 : 383 384.
12. Greenway SC, Benson LN. The use of carvedilol in pediatric heart failure. Cardiovasc Hematol Disord Drug Targets 2006 6 : 35 42.
13. Odland HH, Thaulow EM. Heart failure therapy in children. Expert Rev Cardiovasc Ther 2006 4 : 33 40.
14. Hoch M, Netz H. Heart failure in pediatric patients. Thorac Cardiovasc Surg 2005 53 : 129 34.